Pro-inflammatory cytokines interleukin-1 beta, interleukin 6, and tumor necrosis factor-alpha alter the expression and function of ABCG2 in cervix and gastric cancer cells

Molecular and Cellular Biochemistry

Volumn 363, Issue 1-2, 2012, Pages 385-393

  Mosaffa, Fatemeh ^a   Kalalinia, Fatemeh ^a   Lage, Herman ^b   Afshari, Jalil Tavakol ^a   Behravan, Javad ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

ABCG2; Cervix cancer; Gastric cancer; Gene regulation; Multidrug resistance; Proinflammatory cytokines

Indexed keywords

BETA ACTIN; BREAST CANCER RESISTANCE PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOXANTRONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL; DRUG RESISTANCE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; UTERINE CERVIX CANCER;

ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; MITOXANTRONE; NEOPLASM PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; STOMACH NEOPLASMS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UTERINE CERVICAL NEOPLASMS;

EID: 84857905320     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-1191-9     Document Type: Article

References (37)

1. Teodori E, Dei S, Scapecchi S, Gualtieri F (2002) The medicinal chemistry of multidrug resistance (MDR) reversing drugs. Farmaco 57:385-415 (Pubitemid 34451020)
2. Choi CH (2005) ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal. Cancer Cell Int 5:30
3. Huls M, Russel FG, Masereeuw R (2009) The role of ATP binding cassette transporters in tissue defense and organ regeneration. J Pharmacol Exp Ther 328:3-9
4. Sarkadi B, Ozvegy-Laczka C, Nemet K, Varadi A (2004) ABCG2:a transporter for all seasons. FEBS Lett 567:116-120
5. Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, Schellens JH (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61:3458-3464 (Pubitemid 32695041)
6. Diestra JE, Scheffer GL, Catala I, Maliepaard M, Schellens JH, Scheper RJ, Germa-Lluch JR, Izquierdo MA (2002) Frequent expression of the multi-drug resistance-associated protein BCRP/MXR/ABCP/ABCG2 in human tumours detected by the BXP-21 monoclonal antibody in paraffin-embedded material. J Pathol 198:213-219 (Pubitemid 35243879)
7. Ross DD, Karp JE, Chen TT, Doyle LA (2000) Expression of breast cancer resistance protein in blast cells from patients with acute leukemia. Blood 96:365-368 (Pubitemid 30456496)
8. Mao Q, Unadkat JD (2005) Role of the breast cancer resistance protein (ABCG2) in drug transport. Aaps J 7:E118-E133 (Pubitemid 41554295)
9. Allen JD, Schinkel AH (2002) Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2). Mol Cancer Ther 1:427-434
10. Ho EA, Piquette-Miller M (2006) Regulation of multidrug resistance by pro-inflammatory cytokines. Curr Cancer Drug Targets 6:295-311 (Pubitemid 43961865)
11. Philip M, Rowley DA, Schreiber H (2004) Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol 14:433-439 (Pubitemid 39360991)
12. Haddad JJ (2002) Cytokines and related receptor-mediated signaling pathways. Biochem Biophys Res Commun 297:700-713
13. Dinarello CA (2000) Proinflammatory cytokines. Chest 118:503-508
14. Caruso C, Lio D, Cavallone L, Franceschi C (2004) Aging, longevity, inflammation, and cancer. Ann N Y Acad Sci 1028:1-13 (Pubitemid 40361805)
15. Wilson J, Balkwill F (2002) The role of cytokines in the epithelial cancer microenvironment. Semin Cancer Biol 12:113-120 (Pubitemid 34680740)
16. McRae MP, Brouwer KL, Kashuba AD (2003) Cytokine regulation of P-glycoprotein. Drug Metab Rev 35:19-33 (Pubitemid 36249784)
17. Assenat E, Gerbal-chaloin S, Maurel P, Vilarem MJ, Pascussi JM (2006) Is nuclear factor kappa-B the missing link between inflammation, cancer and alteration in hepatic drug metabolism in patients with cancer? Eur J Cancer 42:785-792
18. Vee ML, Lecureur V, Stieger B, Fardel O (2009) Regulation of drug transporter expression in human hepatocytes exposed to the proinflammatory cytokines tumor necrosis factor-alpha or interleukin-6. Drug Metab Dispos 37:685-693
19. Malekshah OM, Bahrami AR, Afshari JT, Mosaffa F, Behravan J (2011) Correlation between PXR and ABCG2 patterns of mRNA expression in a MCF7 breast carcinoma cell derivative upon induction by proinflammatory cytokines. DNA Cell Biol 30:25-31
20. Mosaffa F, Lage H, Afshari JT, Behravan J (2009) Interleukin-1 beta and tumor necrosis factor-alpha increase ABCG2 expression in MCF-7 breast carcinoma cell line and its mitoxantrone-resistant derivative, MCF-7/MX. Inflamm Res 58:669-676
21. Tahara E (2008) Abnormal growth factor/cytokine network in gastric cancer. Cancer Microenviron 1:85-91. doi:10.1007/s12307-008-0008-1
22. Munagala R, Nagarajan B (2008) Alterations in cytokine levels in cervical carcinoma patients through radiation therapy. Current Science 94:1292-1296 (Pubitemid 351798657)
23. Hilders CG, Houbiers JG, van Ravenswaay Claasen HH, Veldhuizen RW, Fleuren GJ (1993) Association between HLA-expression and infiltration of immune cells in cervical carcinoma. Lab Invest 69:651-659 (Pubitemid 24026846)
24. Minderman H, Suvannasankha A, O'Loughlin KL, Scheffer GL, Scheper RJ, Robey RW, Baer MR (2002) Flow cytometric analysis of breast cancer resistance protein expression and function. Cytometry 48:59-65 (Pubitemid 34591916)
25. Elahian F, Kalalinia F, Behravan J (2009) Dexamethasone downregulates BCRP mRNA and protein expression in breast cancer cell lines. Oncol Res 18:9-15
26. Kalalinia F, Elahian F, Behravan J (2010) Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines. J Cancer Res Clin Oncol 137:321-330
27. Elahian F, Kalalinia F, Behravan J (2010) Evaluation of indomethacin and dexamethasone effects on BCRP-mediated drug resistance in MCF-7 parental and resistant cell lines. Drug Chem Toxicol 33:113-119
28. Slaviero KA, Clarke SJ, Rivory LP (2003) Inflammatory response: an unrecognised source of variability in the pharmacokinetics and pharmacodynamics of cancer chemotherapy. Lancet Oncol 4:224-232 (Pubitemid 36503320)
29. Evseenko DA, Paxton JW, Keelan JA (2007) Independent regulation of apical and basolateral drug transporter expression and function in placental trophoblasts by cytokines, steroids, and growth factors. Drug Metab Dispos 35:595-601 (Pubitemid 46513262)
30. Englund G, Jacobson A, Rorsman F, Artursson P, Kindmark A, Ronnblom A (2007) Efflux transporters in ulcerative colitis: decreased expression of BCRP (ABCG2) and Pgp (ABCB1). Inflamm Bowel Dis 13:291-297 (Pubitemid 46465910)
31. Poller B, Drewe J, Krahenbuhl S, Huwyler J, Gutmann H (2010) Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier. Cell Mol Neurobiol 30:63-70
32. von Wedel-Parlow M, Wolte P, Galla HJ (2009) Regulation of major efflux transporters under inflammatory conditions at the blood-brain barrier in vitro. J Neurochem 111:111-118
33. Takara K, Obata Y, Yoshikawa E, Kitada N, Sakaeda T, Ohnishi N, Yokoyama T (2006) Molecular changes to HeLa cells on continuous exposure to cisplatin or paclitaxel. Cancer Chemother Pharmacol 58:785-793 (Pubitemid 44351259)
34. Yasumoto K, Okamoto S, Mukaida N, Murakami S, Mai M, Matsushima K (1992) Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J Biol Chem 267:22506-22511
35. Lee G, Piquette-Miller M (2001) Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can J Physiol Pharmacol 79:876-884 (Pubitemid 33033546)
36. Kaszubiac A (2007) Adenoviraler Transfer von anti-MDR1 shRNAs Implikationen für die Gentherapie multidrug-resistenter Tumoren. Ph.D.Thesis
37. Stein U, Walther W, Laurencot CM, Scheffer GL, Scheper RJ, Shoemaker RH (1997) Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP. J Natl Cancer Inst 89:807-813 (Pubitemid 27242283)